ID   ALDH1_TANCI             Reviewed;         499 AA.
AC   A0A2I7G3B0;
DT   18-SEP-2019, integrated into UniProtKB/Swiss-Prot.
DT   28-MAR-2018, sequence version 1.
DT   07-APR-2021, entry version 13.
DE   RecName: Full=Aldehyde dehydrogenase 1 {ECO:0000303|PubMed:29122986};
DE            Short=TcALDH1 {ECO:0000303|PubMed:29122986};
DE            EC=1.2.1.5 {ECO:0000269|PubMed:29122986};
DE   AltName: Full=Trans-chrysanthemic acid synthase {ECO:0000305};
DE            EC=1.2.1.- {ECO:0000269|PubMed:29122986};
GN   Name=ALDH1 {ECO:0000303|PubMed:29122986};
OS   Tanacetum cinerariifolium (Dalmatian daisy) (Chrysanthemum
OS   cinerariifolium).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   asterids; campanulids; Asterales; Asteraceae; Asteroideae; Anthemideae;
OC   Anthemidinae; Tanacetum.
OX   NCBI_TaxID=118510;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=29122986; DOI=10.1104/pp.17.01330;
RA   Xu H., Moghe G.D., Wiegert-Rininger K., Schilmiller A.L., Barry C.S.,
RA   Last R.L., Pichersky E.;
RT   "Coexpression analysis identifies two oxidoreductases involved in the
RT   biosynthesis of the monoterpene acid moiety of natural pyrethrin
RT   insecticides in Tanacetum cinerariifolium.";
RL   Plant Physiol. 176:524-537(2018).
RN   [2]
RP   REVIEW.
RX   PubMed=15964038; DOI=10.1016/j.phytochem.2005.05.005;
RA   Matsuda K., Kikuta Y., Haba A., Nakayama K., Katsuda Y., Hatanaka A.,
RA   Komai K.;
RT   "Biosynthesis of pyrethrin I in seedlings of Chrysanthemum
RT   cinerariaefolium.";
RL   Phytochemistry 66:1529-1535(2005).
RN   [3]
RP   REVIEW.
RX   PubMed=30468448; DOI=10.1039/c8np00077h;
RA   Liu Y., Jing S.-X., Luo S.-H., Li S.-H.;
RT   "Non-volatile natural products in plant glandular trichomes: chemistry,
RT   biological activities and biosynthesis.";
RL   Nat. Prod. Rep. 36:626-665(2019).
CC   -!- FUNCTION: Component of the monoterpenoid pyrethrins biosynthesis;
CC       pyrethrins are widely used plant-derived pesticide (PubMed:30468448).
CC       Mediates the conversion of trans-chrysanthemal into trans-chrysanthemic
CC       acid (PubMed:29122986). Can also use octanal, hept-2-enal, dodecanal,
CC       citral, farnesal, citronellal and perillyl aldehyde as substrates
CC       (PubMed:29122986). {ECO:0000269|PubMed:29122986,
CC       ECO:0000303|PubMed:30468448}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aldehyde + H2O + NAD(+) = a carboxylate + 2 H(+) + NADH;
CC         Xref=Rhea:RHEA:16185, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17478, ChEBI:CHEBI:29067, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.2.1.5;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16186;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aldehyde + H2O + NADP(+) = a carboxylate + 2 H(+) + NADPH;
CC         Xref=Rhea:RHEA:11888, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17478, ChEBI:CHEBI:29067, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.2.1.5;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11889;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NADP(+) + octanal = 2 H(+) + NADPH + octanoate;
CC         Xref=Rhea:RHEA:59904, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17935, ChEBI:CHEBI:25646, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; Evidence={ECO:0000269|PubMed:29122986};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59905;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(1R,3R)-chrysanthemal + H2O + NAD(+) = (1R,3R)-chrysanthemate
CC         + 2 H(+) + NADH; Xref=Rhea:RHEA:60708, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:143899, ChEBI:CHEBI:143900;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60709;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(1R,3R)-chrysanthemal + H2O + NADP(+) = (1R,3R)-chrysanthemate
CC         + 2 H(+) + NADPH; Xref=Rhea:RHEA:60716, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:143899, ChEBI:CHEBI:143900;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60717;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(E)-hept-2-enal + H2O + NADP(+) = (E)-hept-2-enoate + 2 H(+) +
CC         NADPH; Xref=Rhea:RHEA:60720, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:143912,
CC         ChEBI:CHEBI:143913; Evidence={ECO:0000269|PubMed:29122986};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60721;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanal + H2O + NADP(+) = dodecanoate + 2 H(+) + NADPH;
CC         Xref=Rhea:RHEA:60724, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:18262, ChEBI:CHEBI:27836, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; Evidence={ECO:0000269|PubMed:29122986};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60725;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=citral + H2O + NADP(+) = 3,7-dimethylocta-2,6-dienoate + 2
CC         H(+) + NADPH; Xref=Rhea:RHEA:60728, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:23316, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:142930;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60729;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NADP(+) + perillyl aldehyde = 2 H(+) + NADPH +
CC         perillate; Xref=Rhea:RHEA:60732, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15421, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:62641;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60733;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E,6E)-farnesal + H2O + NADP(+) = (2E,6E)-farnesoate + 2 H(+)
CC         + NADPH; Xref=Rhea:RHEA:60736, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15894, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:83276; Evidence={ECO:0000269|PubMed:29122986};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60737;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-(-)-citronellal + H2O + NADP(+) = (S)-(-)-citronellate + 2
CC         H(+) + NADPH; Xref=Rhea:RHEA:60740, ChEBI:CHEBI:368,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:143914;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60741;
CC         Evidence={ECO:0000269|PubMed:29122986};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.6 uM for trans-chrysanthemal (in the presence of NAD(+))
CC         {ECO:0000269|PubMed:29122986};
CC         KM=4.4 uM for trans-chrysanthemal (in the presence of NADP(+))
CC         {ECO:0000269|PubMed:29122986};
CC         KM=20.4 uM for NAD(+) {ECO:0000269|PubMed:29122986};
CC         KM=68.6 uM for NADP(+) {ECO:0000269|PubMed:29122986};
CC         Note=kcat is 0.11 sec(-1) with trans-chrysanthemal as substrate (in
CC         the presence of NAD(+)) (PubMed:29122986). kcat is 0.096 sec(-1) with
CC         trans-chrysanthemal as substrate (in the presence of NADP(+))
CC         (PubMed:29122986). kcat is 0.09 sec(-1) with NAD(+) as substrate (in
CC         the presence of trans-chrysanthemal) (PubMed:29122986). kcat is 0.086
CC         sec(-1) with NADP(+) as substrate (in the presence of trans-
CC         chrysanthemal) (PubMed:29122986). {ECO:0000269|PubMed:29122986};
CC   -!- PATHWAY: Isoprenoid biosynthesis. {ECO:0000269|PubMed:29122986}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250|UniProtKB:P51977}.
CC   -!- TISSUE SPECIFICITY: Expressed in flowers and disk florets.
CC       {ECO:0000269|PubMed:29122986}.
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MF497445; AUQ44119.1; -; mRNA.
DR   SMR; A0A2I7G3B0; -.
DR   BioCyc; MetaCyc:MONOMER-20953; -.
DR   GO; GO:0004029; F:aldehyde dehydrogenase (NAD+) activity; IDA:UniProtKB.
DR   GO; GO:0033721; F:aldehyde dehydrogenase (NADP+) activity; IEA:RHEA.
DR   GO; GO:0008299; P:isoprenoid biosynthetic process; IDA:UniProtKB.
DR   Gene3D; 3.40.309.10; -; 1.
DR   Gene3D; 3.40.605.10; -; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016163; Ald_DH_C.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; SSF53720; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   1: Evidence at protein level;
KW   NAD; Oxidoreductase.
FT   CHAIN           1..499
FT                   /note="Aldehyde dehydrogenase 1"
FT                   /id="PRO_0000447849"
FT   NP_BIND         164..167
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:P51977"
FT   NP_BIND         164..166
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:P20000"
FT   NP_BIND         190..193
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:P51977"
FT   NP_BIND         223..224
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:P51977"
FT   NP_BIND         243..248
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:P20000"
FT   NP_BIND         243..244
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:P51977"
FT   NP_BIND         266..268
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   NP_BIND         346..350
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:P00352"
FT   NP_BIND         397..399
FT                   /note="NAD"
FT                   /evidence="ECO:0000250|UniProtKB:P51977"
FT   ACT_SITE        266
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10007"
FT   ACT_SITE        300
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P51977"
FT   SITE            167
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P20000"
SQ   SEQUENCE   499 AA;  53988 MW;  834E841905168901 CRC64;
     MSSGANGNSK SLAYDIKFTK LFINGEFVDS ISGSTFETID PATEEVLATV AEGREEDVDL
     AVKAAREAFD NGPWPRLSGE ARRKILLKFA DLIEENADEI ATLEVIDTGK PFQIARYVEN
     SWTSETFRYF AGAADKIRGA TLKMSSDFQA YTLREPIGVV GHIIPWNAPA YLFAMKVAPA
     LAAGCTVVIK PAENTPLVGL FMAYLSKLAG VPDGVINVVN GFGSTAGAAV SSHMDIDAVT
     FTGSTKVGRT IMQAAAASNL KPVSLELGGK SPFIVFDDAD IEKAAEIAVL GVLSNKGELC
     VAGSRVFVHE GIYDAFVKKL EATVKNWATG DRFDAATRHG PQNNKQQYEK VLSYIELGKK
     EGATLVTGGK PFGNKGYYIE PTLFTNVTDE MTIAKEEIFG PVIMVLKFKT IEEVIRRANA
     TTYGLAAGIM TKNIDIANTV TRSIRAGSVW VNCYLALDRD TPFGGYKMSG FGREQGLEAL
     EHYLQVKTVT TPIYNSPWL
//
